Mirae Asset Global Investments
CYTK icon

Mirae Asset Global Investments’s Cytokinetics CYTK Stock Holding History

Mirae Asset Global Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Sell
6,063
-361
-6% -$25.9K ﹤0.01% 974
2026
Q1 		$423K Buy
6,424
+483
+8% +$30.7K ﹤0.01% 968
2025
Q4 		$377K Buy
5,941
+1,315
+28% +$81.8K ﹤0.01% 1044
2025
Q3 		$254K Buy
4,626
+13
+0.3% +$536 ﹤0.01% 1092
2025
Q2 		$152K Buy
4,613
+683
+17% +$23.8K ﹤0.01% 1081
2025
Q1 		$170K Sell
3,930
-3
-0.1% -$138 ﹤0.01% 1071
2024
Q4 		$186K Sell
3,933
-323
-8% -$16.8K ﹤0.01% 1056
2024
Q3 		$223K Buy
4,256
+833
+24% +$46.4K ﹤0.01% 1071
2024
Q2 		$184K Sell
3,423
-56,000
-94% -$3.38M ﹤0.01% 1056
2024
Q1 		$2.33M Buy
59,423
+5,676
+11% +$439K 0.01% 1127
2023
Q4 		$4.49M Buy
53,747
+2,063
+4% +$74.7K 0.01% 925
2023
Q3 		$1.52M Buy
51,684
+359
+0.7% +$12K ﹤0.01% 1308
2023
Q2 		$1.68M Sell
51,325
-10,399
-17% -$385K ﹤0.01% 1297
2023
Q1 		$2.17M Buy
61,724
+8,565
+16% +$349K 0.01% 1172
2022
Q4 		$2.44M Buy
53,159
+16,117
+44% +$693K 0.01% 1055
2022
Q3 		$1.79M Buy
37,042
+11,441
+45% +$551K ﹤0.01% 1183
2022
Q2 		$1.01M Buy
+25,601
New +$1.03M ﹤0.01% 1397

Other funds holding CYTK

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Mirae Asset Global Investments's CYTK Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Cytokinetics (CYTK) stake by 5.6% in Q2 2026, selling an estimated $25.9K and leaving 6,063 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #974.

Mirae Asset Global Investments first reported a position in CYTK in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.49M in Q4 2023. 88 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Mirae Asset Global Investments held 6,063 shares of Cytokinetics worth $517K as of Q2 2026.
  • Mirae Asset Global Investments sold 361 Cytokinetics shares in Q2 2026, an estimated $25.9K.
  • Cytokinetics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #974 holding.
  • Mirae Asset Global Investments first reported a position in Cytokinetics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Cytokinetics position peaked at $4.49M in Q4 2023.
  • 88 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.